epidemiolog
laboratori
studi
shown
green
tea
green
tea
catechin
exert
benefici
effect
varieti
diseas
includ
cancer
metabol
syndrom
infecti
diseas
neurodegen
diseas
case
epigallocatechin
gallat
egcg
shown
play
central
role
effect
green
tea
catechin
plant
sourc
also
shown
health
benefit
mani
studi
reveal
bind
egcg
catechin
protein
involv
action
mechan
comput
dock
analysi
cmda
xray
crystallograph
analysi
xca
provid
detail
inform
catechinprotein
interact
sever
studi
reveal
galloyl
moieti
anchor
cleft
protein
interact
hydroxyl
group
explain
higher
activ
galloyl
catechin
egcg
epicatechin
gallat
nongalloyl
catechin
paper
review
result
cmda
xca
egcg
plant
catechin
understand
catechinprotein
interact
expect
develop
new
drug
healthpromot
properti
green
tea
green
tea
catechin
gtc
reveal
benefici
effect
varieti
diseas
cancer
metabol
syndrom
met
infecti
diseas
neurodegen
diseas
case
epigallocatechin
gallat
egcg
believ
play
central
role
biolog
action
green
tea
plant
catechin
sourc
also
show
health
benefit
egcg
catechin
contribut
effect
mainli
antioxid
prooxid
properti
figur
addit
mani
studi
reveal
bind
egcg
catechin
protein
involv
action
mechan
among
studi
catechinprotein
interact
arora
et
al
appear
first
provid
detail
inform
interact
serum
albumin
sa
catechin
determin
physicochem
method
sever
method
demonstr
catechinprotein
bind
interact
includ
equilibrium
dialysi
interact
includ
equilibrium
dialysi
phmetric
spectrophotometr
method
affin
chromatographi
surfac
plasmon
reson
nuclear
magnet
reson
xray
crystallograph
analysi
xca
comput
molecular
dock
analysi
cmda
cmda
use
reveal
intricaci
interact
sa
catechin
exampl
data
obtain
experi
includ
cmda
indic
egcg
bind
residu
locat
subdomain
iia
iiia
human
sa
specif
interact
occur
residu
egcg
shown
bind
iia
iiia
domain
bovin
sa
induc
bindingdepend
conform
chang
protein
recent
ikeda
et
al
demonstr
gallat
ester
moieti
posit
enhanc
bind
abil
catechin
bovin
sa
interact
via
stack
figur
egcg
also
shown
interact
locat
surfac
bsa
hydrogen
bond
treatment
human
hepatoma
cell
egcg
induc
nonapoptot
cell
death
serum
protein
fetal
bovin
sa
bovin
sa
absent
toxic
egcg
caus
bind
variou
cellular
protein
poli
adpribos
polymeras
reduc
addit
sa
cmda
indic
bovin
sa
stronger
affin
egcg
protein
sa
may
act
protein
carrier
bind
inform
may
use
develop
drug
deliveri
system
shi
et
al
appli
smallangl
xray
scatter
studi
complex
structur
bovin
sa
bound
catechin
egcg
result
indic
egcg
stronger
abil
catechin
promot
complex
format
aggreg
aggreg
egcg
complex
denser
core
rel
smooth
surfac
wherea
catechin
aggreg
loos
pack
rough
surfac
suggest
role
gallat
moieti
aggreg
format
find
provid
basic
understand
catechininduc
format
aggreg
protein
complex
previou
review
discuss
catechinprotein
interact
part
mechan
catechin
benefici
action
health
note
import
cmda
xca
elucid
cmda
use
reveal
intricaci
interact
sa
catechin
exampl
data
obtain
experi
includ
cmda
indic
egcg
bind
residu
locat
subdomain
iia
iiia
human
sa
specif
interact
occur
residu
egcg
shown
bind
iia
iiia
domain
bovin
sa
induc
bindingdepend
conform
chang
protein
recent
ikeda
et
al
demonstr
gallat
ester
moieti
posit
enhanc
bind
abil
catechin
bovin
sa
interact
via
stack
figur
egcg
also
shown
interact
locat
surfac
bsa
hydrogen
bond
treatment
human
hepatoma
cell
egcg
induc
nonapoptot
cell
death
serum
protein
fetal
bovin
sa
bovin
sa
absent
toxic
egcg
caus
bind
variou
cellular
protein
poli
adpribos
polymeras
reduc
addit
sa
cmda
indic
bovin
sa
stronger
affin
egcg
protein
sa
may
act
protein
carrier
bind
inform
may
use
develop
drug
deliveri
system
shi
et
al
appli
smallangl
xray
scatter
studi
complex
structur
bovin
sa
bound
catechin
egcg
result
indic
egcg
stronger
abil
catechin
promot
complex
format
aggreg
aggreg
egcg
complex
denser
core
rel
smooth
surfac
wherea
catechin
aggreg
loos
pack
rough
surfac
suggest
role
gallat
moieti
aggreg
format
find
provid
basic
understand
catechininduc
format
aggreg
protein
complex
previou
review
discuss
catechinprotein
interact
part
mechan
catechin
benefici
action
health
note
import
cmda
xca
elucid
action
mechan
catechin
present
review
expand
literatur
search
review
result
analys
egcg
catechinrel
compound
figur
understand
catechinprotein
interact
expect
develop
new
drug
healthpromot
properti
molecul
action
mechan
catechin
present
review
expand
literatur
search
review
result
analys
egcg
catechinrel
compound
figur
understand
catechinprotein
interact
expect
develop
new
drug
healthpromot
properti
term
creativ
common
attributionnoncommercialsharealik
licens
plant
polyphenol
anticanc
properti
catechin
especi
egcg
extens
studi
plant
polyphenol
sever
epidemiolog
studi
show
benefici
effect
green
tea
gtc
cancer
molecular
bind
interact
gtc
specif
protein
involv
tea
anticanc
mechan
cmda
use
reveal
interact
mmp
cancer
cell
believ
involv
cell
prolifer
invas
metastasi
exampl
bu
et
al
report
synthet
mmp
inhibitor
batimastat
exhibit
inhibitori
effect
tumor
growth
tissu
invas
intrahepat
lung
metastasi
nude
mice
model
liver
cancer
batimastat
prolong
surviv
anim
egcg
ecg
shown
inhibit
enzymat
activ
mmp
gtc
green
tea
proven
record
inhibit
cancer
metastasi
sever
anim
experi
discuss
previous
cmda
demonstr
bind
interact
gtc
mmp
includ
gallat
group
import
establish
strong
interact
egcg
ecg
activ
inhibit
egcg
ecg
ec
egc
result
show
interact
egcg
sever
amino
acid
residu
activ
site
residu
interact
energi
exceed
kcalmol
result
chemic
bond
hydrogen
bond
interact
residu
also
shown
involv
interact
ec
egc
ecg
galloyl
moieti
egcg
interact
amino
acid
residu
due
presenc
galloyl
residu
egcg
ecg
higher
bind
affin
ec
egc
indic
import
role
inhibitori
action
activ
case
trypsin
may
associ
prolifer
invas
metastasi
cancer
cell
degrad
extracellular
matrix
protein
shi
et
al
suggest
figur
cmda
egcg
bind
bovin
sa
interact
egcg
b
shown
green
broken
arrow
repres
hydrogen
bond
gallat
group
form
hydrophob
bond
b
cite
term
creativ
common
attributionnoncommercialsharealik
licens
plant
polyphenol
anticanc
properti
catechin
especi
egcg
extens
studi
plant
polyphenol
sever
epidemiolog
studi
show
benefici
effect
green
tea
gtc
cancer
molecular
bind
interact
gtc
specif
protein
involv
tea
anticanc
mechan
cmda
use
reveal
interact
mmp
cancer
cell
believ
involv
cell
prolifer
invas
metastasi
exampl
bu
et
al
report
synthet
mmp
inhibitor
batimastat
exhibit
inhibitori
effect
tumor
growth
tissu
invas
intrahepat
lung
metastasi
nude
mice
model
liver
cancer
batimastat
prolong
surviv
anim
egcg
ecg
shown
inhibit
enzymat
activ
mmp
gtc
green
tea
proven
record
inhibit
cancer
metastasi
sever
anim
experi
discuss
previous
cmda
demonstr
bind
interact
gtc
mmp
includ
gallat
group
import
establish
strong
interact
egcg
ecg
activ
inhibit
egcg
ecg
ec
egc
result
show
interact
egcg
sever
amino
acid
residu
activ
site
residu
interact
energi
exceed
kcalmol
result
chemic
bond
hydrogen
bond
interact
residu
also
shown
involv
interact
ec
egc
ecg
galloyl
moieti
egcg
interact
amino
acid
residu
due
presenc
galloyl
residu
egcg
ecg
molecul
higher
bind
affin
ec
egc
indic
import
role
inhibitori
action
activ
case
trypsin
may
associ
prolifer
invas
metastasi
cancer
cell
degrad
extracellular
matrix
protein
shi
et
al
suggest
bind
egcg
trypsin
catalyt
caviti
involv
hydrogen
bond
provid
hydroxyl
group
galloyl
residu
wherea
catechin
use
bring
figur
main
contributor
hydrogen
bond
bind
egcg
shown
bind
catechin
egcg
exhibit
much
stronger
inhibitori
activ
catechin
data
consist
cui
et
al
show
trypsincatechin
complex
residu
common
contribut
conserv
hydrogen
bond
interact
hydrophob
contact
thu
catechin
occup
catalyt
pocket
trypsin
would
hinder
substrat
bind
lead
inhibit
proteindegrad
activ
find
provid
explan
higher
effici
galloyl
catechin
nongalloyl
catechin
bind
egcg
trypsin
catalyt
caviti
involv
hydrogen
bond
provid
hydroxyl
group
galloyl
residu
wherea
catechin
use
bring
figur
main
contributor
hydrogen
bond
bind
egcg
shown
bind
catechin
egcg
exhibit
much
stronger
inhibitori
activ
catechin
data
consist
cui
et
al
show
trypsincatechin
complex
residu
common
contribut
conserv
hydrogen
bond
interact
hydrophob
contact
thu
catechin
occup
catalyt
pocket
trypsin
would
hinder
substrat
bind
lead
inhibit
proteindegrad
activ
find
provid
explan
higher
effici
galloyl
catechin
nongalloyl
catechin
cmda
also
suggest
particular
pose
egcg
may
lead
coval
modif
ntermin
threonin
proteasom
subunit
chymotrypsinlik
activ
site
methyl
egcg
may
reduc
biolog
activ
egcg
proteasom
chymotrypsinlik
inhibitori
activ
methyl
disrupt
abil
ecg
egcg
interact
subunit
cmda
show
methyl
caus
ester
carbon
catechin
move
away
block
entir
impair
abil
catechin
dock
well
find
suggest
methyl
inhibit
bind
catechin
proteasom
subunit
would
reduc
anticanc
activ
kongpichitchok
et
al
examin
effect
gallic
acid
figur
protein
kinas
c
pkc
show
content
gallic
acid
increas
depend
degre
ferment
tea
gallic
acid
reduc
reactiv
oxygen
speci
ro
phorbol
esteractiv
macrophag
immunoblot
cmda
reveal
gallic
acid
abl
block
phosphoryl
occupi
phorbol
ester
bind
site
protein
figur
thu
gallic
acid
certain
concentr
may
protect
cell
death
previous
laminin
receptor
pathway
egcg
shown
induc
upregul
cgmp
initi
cancer
cellspecif
cell
death
activ
sphingomyelinas
indic
involv
activ
apoptosi
thu
futur
studi
need
clarifi
effect
gallic
acid
egcgmedi
apoptosi
cancer
cell
cmda
also
suggest
particular
pose
egcg
may
lead
coval
modif
ntermin
threonin
proteasom
subunit
chymotrypsinlik
activ
site
methyl
egcg
may
reduc
biolog
activ
egcg
proteasom
chymotrypsinlik
inhibitori
activ
methyl
disrupt
abil
ecg
egcg
interact
subunit
cmda
show
methyl
caus
ester
carbon
catechin
move
away
block
entir
impair
abil
catechin
dock
well
find
suggest
methyl
inhibit
bind
catechin
proteasom
subunit
would
reduc
anticanc
activ
kongpichitchok
et
al
examin
effect
gallic
acid
figur
protein
kinas
c
pkc
show
content
gallic
acid
increas
depend
degre
ferment
tea
gallic
acid
reduc
reactiv
oxygen
speci
ro
phorbol
esteractiv
macrophag
immunoblot
cmda
reveal
gallic
acid
abl
block
phosphoryl
occupi
phorbol
ester
bind
site
protein
figur
thu
gallic
acid
certain
concentr
may
protect
cell
death
previous
laminin
receptor
pathway
egcg
shown
induc
upregul
cgmp
initi
cancer
cellspecif
cell
death
activ
sphingomyelinas
indic
involv
activ
apoptosi
thu
futur
studi
need
clarifi
effect
gallic
acid
egcgmedi
apoptosi
cancer
cell
phosphoryl
occupi
phorbol
ester
bind
site
protein
figur
thu
gallic
acid
certain
concentr
may
protect
cell
death
previous
laminin
receptor
pathway
egcg
shown
induc
upregul
cgmp
initi
cancer
cellspecif
cell
death
activ
sphingomyelinas
indic
involv
activ
apoptosi
thu
futur
studi
need
clarifi
effect
gallic
acid
egcgmedi
apoptosi
cancer
cell
dutta
et
al
synthes
novel
catechinecbas
conjug
resorcinol
phloroglucinol
increas
number
phenol
oh
group
found
conjug
effect
inhibitor
ribonucleas
parent
catechin
indic
import
number
phenol
hydroxyl
group
inhibit
ribonucleolyt
activ
cmda
reveal
precis
proteincatechin
interact
deriv
ec
compound
also
show
inhibit
angiogenininduc
angiogenesi
sinc
angiogenesi
associ
tumor
growth
catechin
conjug
may
potenti
role
anticanc
agent
find
chemotherapeut
agent
shin
et
al
examin
variou
plantderiv
compound
includ
chalcon
show
poor
interact
dna
low
risk
mutagen
chromenon
also
known
anticanc
effect
therefor
hybrid
chalcon
chromenon
expect
better
chemotherapeut
agent
shin
et
al
synthes
chromenylchalcon
compound
screen
cytotox
human
colorect
cancer
cell
line
chromenylchalcon
show
halfmaxim
inhibitori
concentr
nm
compar
catechin
gallat
ecg
compound
inhibit
aurora
kinas
mechan
could
examin
cmda
find
may
provid
use
inform
synthes
cancer
therapeut
prevent
chromenylchalcon
catechin
compound
wnt
signal
play
crucial
role
tumor
cell
prolifer
correl
accumul
uncontrol
express
lead
fibromatosi
sarcoma
mesenchym
tumor
format
iftikhar
et
al
use
cmda
found
bind
energi
known
inhibitor
isorhamnetin
fisetin
genistein
silibinin
kcalmol
correspond
valu
catechin
also
kcalmol
interact
catechin
involv
six
hydrogen
bond
two
residu
one
respect
figur
interact
ring
hydrophob
interact
inhibitor
found
residu
flavonoid
famili
member
cell
factor
compet
bind
share
common
bind
residu
find
may
use
screen
inhibitor
anticanc
drug
clinic
studi
demonstr
correl
cyclindepend
kinas
malign
progress
pancreat
cancer
phytochem
wedelolacton
catechin
analyz
sever
method
includ
cmda
select
antipancreat
cancer
compound
compound
use
less
bind
energi
inhibit
activ
suggest
potenti
drug
treat
pancreat
cancer
heat
shock
protein
hsp
serv
potenti
target
therapi
breast
cancer
dunna
et
al
select
seven
establish
hsp
inhibitor
egcg
consid
seven
inhibitor
parent
compound
ligandbas
search
carri
show
similar
pubchem
databas
list
million
compound
among
compound
highest
dock
rerank
score
new
candid
pubchem
cid
demonstr
consider
affin
toward
identifi
studi
serv
model
search
anticanc
drug
base
proteinligand
interact
catenin
involv
six
hydrogen
bond
two
residu
one
respect
figur
interact
ring
hydrophob
interact
inhibitor
found
residu
flavonoid
famili
member
cell
factor
compet
bind
share
common
bind
residu
find
may
use
screen
inhibitor
anticanc
drug
clinic
studi
demonstr
correl
cyclindepend
kinas
malign
progress
pancreat
cancer
phytochem
wedelolacton
catechin
analyz
sever
method
includ
cmda
select
antipancreat
cancer
compound
compound
use
less
bind
energi
inhibit
activ
suggest
potenti
drug
treat
pancreat
cancer
heat
shock
protein
hsp
serv
potenti
target
therapi
breast
cancer
dunna
et
al
select
seven
establish
hsp
inhibitor
egcg
figur
cmda
complex
green
dot
line
orang
line
repres
hydrogen
bond
interact
respect
reproduc
term
creativ
common
attributionnoncommercialsharealik
licens
use
singlecel
alkalin
gel
electrophoresi
comet
assay
farhan
et
al
found
rel
effici
cellular
dna
breakag
order
egcg
egc
ec
catechin
show
dna
breakag
caus
mobil
chromatinbound
copper
ion
gener
ro
order
dna
bind
affin
confirm
cmda
thermodynam
studi
use
calf
thymu
dna
result
suggest
synthesi
novel
anticanc
molecul
mani
galloyl
moieti
possibl
would
provid
increas
number
hydroxyl
group
may
facilit
bind
molecul
cellular
dna
chen
et
al
predict
serinethreonin
kinas
ribosom
kinas
would
molecular
target
egcg
cmda
combin
pulldown
assay
indic
egcg
bind
catalyt
domain
vitro
ex
vivo
sinc
rsk
inhibit
result
decreas
cell
migrat
prolifer
cancer
cell
egcg
may
use
prevent
cancer
cytosol
sulfotransferas
sult
phase
ii
detoxif
enzym
regul
activ
hundr
signal
small
molecul
alloster
effect
genet
variat
associ
risk
certain
type
cancer
includ
lung
cancer
use
spinlabel
triangul
method
cmda
cook
et
al
examin
structur
catechin
allostericbind
site
found
egcg
could
control
open
closur
state
find
may
use
understand
alloster
regul
egcg
compound
develop
drug
enhanc
diminish
sult
activ
hepat
sinusoid
obstruct
syndrom
hso
rare
lifethreaten
liver
diseas
jing
et
al
investig
involv
nuclear
factor
erythroid
factor
antioxid
signal
pathway
protect
catechin
monocrotalin
mct
induc
hso
catechin
protect
hepat
obstruct
mctinduc
hso
rat
attenu
format
ro
human
hepat
sinusoid
endotheli
cell
enhanc
nuclear
transloc
liver
monocrotalinetr
rat
mtctreat
cell
increas
express
gene
cmda
indic
potenti
interact
catechin
bind
site
protein
kelchlik
echassoci
demonstr
critic
involv
pathway
protect
catechin
mtcinduc
hso
studi
assess
inhibitori
effect
aqueou
methanol
extract
plant
use
tradit
chines
medicin
phase
metabol
enzym
aqueou
extract
acacia
catechu
contain
catechin
ec
ecg
inhibit
activ
appli
dose
cmda
major
compound
show
hesperidin
rutin
highest
fit
score
activ
site
bind
energi
kcalmol
respect
correspond
valu
catechin
kcalmol
show
weak
inhibitor
compound
may
interfer
metabol
concomitantli
administ
drug
flavonoid
found
possess
anticanc
activ
modul
differ
enzym
receptor
zhang
et
al
examin
bind
flavonoid
inhibit
activ
use
cmda
method
result
indic
among
variou
flavonoid
six
inhibitorschrysin
fisetin
galangin
genistein
quercetin
kaempferolshow
strong
activ
bind
energi
rang
kcalmol
correspond
valu
catechin
ec
greater
kcalmol
indic
catechin
weak
inhibitor
assess
bind
effici
flavonoid
oh
oh
bring
favor
hydrogen
bond
format
wherea
cring
are
hydrogenbond
forc
van
der
waal
interact
residu
contribut
bind
affin
bind
featur
flavonoid
inhibitor
may
provid
valuabl
insight
develop
inhibitor
chemoprevent
agent
transduc
activ
transcript
overexpress
report
mani
tumor
type
suggest
inhibit
anticanc
effect
efferth
et
al
use
known
inhibitor
refer
compound
studi
sever
potenti
compound
method
includ
cmda
among
compound
assess
six
compound
includ
egcg
bind
energi
lower
around
kcalmol
suggest
potent
inhibitor
pki
valu
gingektin
withaferin
egcg
respect
support
three
repres
compound
better
inhibitor
amino
acid
residu
involv
bind
interact
gingektin
withaferin
egcg
figur
thu
amino
acid
particip
egcgprotein
bind
also
involv
bind
least
one
three
compound
except
amino
acid
involv
bind
compound
locat
src
homolog
domain
protein
figur
sampl
compound
provid
studi
would
use
select
design
phytochem
drug
cancer
chemoprevent
nad
depend
histon
deacetylas
play
import
role
variou
biolog
event
cancer
longev
dnarepair
inflamm
rahnastrilla
et
al
found
flavonoid
affect
activ
structuredepend
manner
potent
activ
cyanidin
produc
increas
activ
flavonoid
induc
increas
cyanidin
also
increas
express
human
colorect
cancer
cell
bind
activ
chang
conform
polypeptid
loop
near
acetyl
peptid
substrat
bind
site
lead
activ
gcg
ecg
show
signific
inhibit
cmda
predict
bind
inhibitor
disturb
nad
bind
enzym
addit
abovement
studi
discuss
result
cmda
relat
interact
egcg
cancerrel
protein
includ
glucos
regul
insulinlik
growth
receptor
vascular
endotheli
growth
factor
vegf
zeta
chain
cell
receptor
associ
protein
kinas
tyrosin
kinas
tumor
necrosi
factor
tnf
receptor
associ
factor
urokinas
chymotrypsin
lipas
hydroxymethylglutaryl
coa
reductas
leukotrien
hydrolas
dna
methyltransferas
protein
phosphatas
signal
transduc
activ
transcript
sever
epidemiolog
studi
shown
green
tea
gtc
benefici
effect
neurodegen
disord
includ
alzheim
diseas
ad
parkinson
diseas
pd
cognit
dysfunct
exampl
metaanalysi
observ
studi
show
tea
intak
significantli
reduc
risk
cognit
disord
odd
ratio
confid
interv
crosssect
studi
patient
mean
age
japan
found
associ
low
green
tea
consumpt
p
trend
higher
preval
cognit
impair
anim
studi
support
human
result
exampl
unno
et
al
demonstr
ingest
gtc
suppress
brain
dysfunct
age
mice
sever
investig
reveal
molecular
mechan
catechin
effect
neurodegen
disord
use
cmda
previou
paper
review
use
cmda
assess
interact
catechin
protein
relat
neurodegen
diseas
addit
inform
introduc
next
ad
common
progress
neurodegen
disord
caus
dementia
involv
loss
structur
function
cholinerg
neuron
inhibitor
acetylcholinesteras
ach
butyrylcholinesteras
bche
potenti
treatment
ad
cmda
reveal
polyphenol
inhibit
bind
ach
bche
bind
energi
egcg
ach
bche
lowest
kcalmol
respect
studi
suggest
gtc
inhibit
ach
bche
enhanc
cholinerg
neurotransmiss
prolong
transmiss
time
sinc
ach
molecul
remain
synapt
cleft
ach
inhibitor
rather
bche
suggest
standard
drug
treatment
ad
similarli
chen
et
al
examin
ach
inhibitor
present
plant
avail
market
use
cmda
stabil
dock
proteinligand
complex
assess
molecular
dynam
simul
inhibitori
assay
demonstr
uncaria
rhynchophylla
portulaca
oleracea
extract
ach
inhibitori
activ
cmda
indic
catechin
present
u
sever
epidemiolog
studi
shown
green
tea
gtc
benefici
effect
neurodegen
disord
includ
alzheim
diseas
ad
parkinson
diseas
pd
cognit
dysfunct
exampl
metaanalysi
observ
studi
show
tea
intak
significantli
reduc
risk
cognit
disord
odd
ratio
confid
interv
crosssect
studi
patient
mean
age
japan
found
associ
low
green
tea
consumpt
p
trend
higher
preval
cognit
impair
anim
studi
support
human
result
exampl
unno
et
al
demonstr
ingest
gtc
suppress
brain
dysfunct
age
mice
sever
investig
reveal
molecular
mechan
catechin
effect
neurodegen
disord
use
cmda
previou
paper
review
use
cmda
assess
interact
catechin
protein
relat
neurodegen
diseas
addit
inform
introduc
next
ad
common
progress
neurodegen
disord
caus
dementia
involv
loss
structur
function
cholinerg
neuron
inhibitor
acetylcholinesteras
ach
butyrylcholinesteras
bche
potenti
treatment
ad
cmda
reveal
polyphenol
inhibit
bind
ach
bche
bind
energi
egcg
ach
bche
lowest
kcalmol
respect
studi
suggest
gtc
inhibit
ach
bche
enhanc
cholinerg
neurotransmiss
prolong
transmiss
time
sinc
ach
molecul
remain
synapt
cleft
ach
inhibitor
rather
bche
suggest
standard
drug
treatment
ad
similarli
chen
et
al
examin
ach
inhibitor
present
plant
avail
market
use
cmda
stabil
dock
proteinligand
complex
assess
molecular
dynam
simul
inhibitori
assay
demonstr
uncaria
rhynchophylla
portulaca
oleracea
extract
ach
inhibitori
activ
cmda
indic
catechin
present
u
rhynchophylla
dopamin
norepinephrin
present
p
oleracea
best
dock
score
interact
energi
suggest
compound
may
use
treat
ad
studi
explor
bind
mode
catechin
molecular
target
potenti
role
pd
cmda
method
reveal
monoamin
oxidaseb
promis
target
nmethyldaspart
receptor
least
favor
target
catechin
benzopyran
skeleton
phenyl
group
substitut
hydroxyl
ester
group
identifi
common
structur
requir
major
target
protein
find
suggest
egcg
promis
lead
develop
multitarget
drug
pd
previou
studi
report
egcg
bind
unfold
nativ
polypeptid
prevent
convers
amyloid
fibril
amyloidogen
mutant
chicken
cystatin
gener
amyloidform
model
protein
undergo
fibril
format
domainswap
mechan
wang
et
al
demonstr
egcg
potent
inhibitor
fibril
format
cmda
suggest
egcg
prevent
fibril
format
stabil
molecul
nativelik
state
oppos
redirect
aggreg
toward
disord
amorph
aggreg
studi
suggest
egcg
gener
inhibitor
amyloidfibril
format
mechan
may
differ
protein
protein
find
may
use
understand
catechin
inhibitori
effect
protein
fibril
format
caus
certain
form
brain
dysfunct
amyotroph
later
sclerosi
neurodegen
disord
mutat
superoxid
dismutas
protein
contribut
rapid
diseas
progress
srinivasan
rajasekaran
examin
inhibitori
action
egcg
nativ
mutant
includ
cmda
result
show
protein
destabil
increas
propens
mutant
form
regain
bound
egcg
bind
egcg
mutant
reduc
format
toxic
aggreg
suggest
therapeut
potenti
treatment
neurodegen
diseas
immunoglobulin
light
chain
amyloidosi
diseas
caus
fibril
format
serum
immunoglobulin
light
chain
common
caus
acquir
amyloid
polyneuropathi
egcg
known
interfer
fibril
format
induc
protein
aggreg
hora
et
al
show
nmrguid
cmda
identifi
two
distinct
egcg
bind
site
includ
prolin
bind
residu
figur
egcginduc
protein
complex
unstructur
egcg
react
select
amyloidogen
mutant
propos
mechan
consist
three
step
nativ
monom
convert
via
partial
unfold
intermedi
amyloid
fibril
ii
egcg
bind
either
low
affin
precipit
higher
affin
iii
egcg
molecul
recruit
bind
site
turn
result
associ
protein
lead
eventu
precipit
figur
make
egcg
promis
lead
structur
capabl
handl
immens
sequenc
variabl
immunoglobulin
light
chain
syndrom
ds
genet
disord
caus
presenc
part
third
copi
chromosom
diseas
associ
decreas
amount
matur
nerv
growth
factor
ngf
downregul
tissu
plasminogen
activ
activ
plasminogen
plasmin
enzym
convert
prongf
matur
ngf
ii
overexpress
degrad
ngf
et
al
propos
addit
way
egcg
might
affect
trisomi
name
modifi
proteolyt
activ
enzym
involv
although
egcg
previous
shown
inhibit
urokinas
dock
well
inhibit
tissu
plasminogen
activ
egcg
report
inhibit
dock
well
thu
egcg
may
inhibit
brain
slow
degrad
ngf
therebi
prevent
ds
syndrom
ds
genet
disord
caus
presenc
part
third
copi
chromosom
diseas
associ
decreas
amount
matur
nerv
growth
factor
ngf
downregul
tissu
plasminogen
activ
activ
plasminogen
plasmin
enzym
convert
prongf
matur
ngf
ii
overexpress
degrad
ngf
et
al
propos
addit
way
egcg
might
affect
trisomi
name
modifi
proteolyt
activ
enzym
involv
although
egcg
previous
shown
inhibit
urokinas
dock
well
inhibit
tissu
plasminogen
activ
egcg
report
inhibit
dock
well
thu
egcg
may
inhibit
brain
slow
degrad
ngf
therebi
prevent
ds
abnorm
measur
met
includ
bodi
mass
index
bodi
fat
waist
circumfer
blood
pressur
triglycerid
highdens
lipoprotein
total
cholesterol
blood
glucos
hemoglobin
patient
met
elev
risk
diabet
mellitu
cardiovascular
diseas
sever
studi
includ
epidemiolog
studi
shown
green
tea
egcg
benefici
effect
diseas
exampl
clinic
trial
found
decreas
waist
circumfer
patient
diabet
ingest
catechinrich
green
tea
significantli
greater
patient
ingest
green
tea
much
lower
level
catechin
cmda
reveal
mode
interact
catechin
protein
relat
met
relat
diseas
exemplifi
studi
examin
next
rashid
et
al
report
ec
extract
averrhoa
carambola
l
peel
bioactiv
compound
inhibit
adipogenesi
obes
cmda
suggest
ec
appear
bind
receptor
includ
ccaatenhancerbind
peroxisom
proliferatoractiv
inhibitor
acarbos
common
oral
antidiabet
drug
jhong
et
al
screen
inhibitor
natur
compound
use
cmda
three
select
polyphenol
compound
catechin
quercetin
rutin
inhibit
activ
enzym
appli
less
mm
compar
effect
acarbos
mollenoulloa
et
al
report
mode
bind
gproteincoupl
receptor
ec
similar
agonist
wagner
et
al
attempt
reveal
molecular
mechan
abnorm
measur
met
includ
bodi
mass
index
bodi
fat
waist
circumfer
blood
pressur
triglycerid
highdens
lipoprotein
total
cholesterol
blood
glucos
hemoglobin
patient
met
elev
risk
diabet
mellitu
cardiovascular
diseas
sever
studi
includ
epidemiolog
studi
shown
green
tea
egcg
benefici
effect
diseas
exampl
clinic
trial
found
decreas
waist
circumfer
patient
diabet
ingest
catechinrich
green
tea
significantli
greater
patient
ingest
green
tea
much
lower
level
catechin
cmda
reveal
mode
interact
catechin
protein
relat
met
relat
diseas
exemplifi
studi
examin
next
rashid
et
al
report
ec
extract
averrhoa
carambola
l
peel
bioactiv
compound
inhibit
adipogenesi
obes
cmda
suggest
ec
appear
bind
receptor
includ
ccaatenhancerbind
peroxisom
proliferatoractiv
inhibitor
acarbos
common
oral
antidiabet
drug
jhong
et
al
screen
inhibitor
natur
compound
use
cmda
three
select
polyphenol
compound
catechin
quercetin
rutin
inhibit
activ
enzym
appli
less
mm
compar
effect
acarbos
mollenoulloa
et
al
report
mode
bind
gproteincoupl
receptor
ec
similar
agonist
wagner
et
al
attempt
reveal
molecular
mechan
egcgrich
green
tea
extract
affect
glucos
metabol
increas
fit
lifespan
fruit
fli
drosophila
melanogast
cmda
indic
egcg
inhibit
glucos
gener
bind
activ
site
lead
calor
restrictionlik
effect
would
extend
lifespan
sun
et
al
examin
interact
pancreat
ppa
tea
polyphenol
biochem
physicochem
method
cmda
fluoresc
quench
differenti
scan
calorimetri
show
galloyl
moieti
interact
ppa
hydrogen
bond
three
hydroxyl
group
catalyt
amino
acid
sidechain
also
hydrophob
interact
activ
site
enzym
tea
polyphenol
includ
egcg
ecg
egc
ec
gallat
digal
bind
constant
obtain
fluoresc
quench
isotherm
titrat
calorimetri
similar
among
polyphenol
suggest
bind
ppa
primarili
includ
interact
tri
vicin
tri
activ
site
enzym
find
suggest
galloyl
moieti
polyphenol
bind
ppa
promot
polyphenol
enter
associ
activ
site
enzym
flavonoid
may
reduc
risk
cardiovascular
diseas
inhibit
activ
kinas
fyn
lyn
src
pkc
xca
show
flavonoid
ring
system
hydroxyl
substitut
import
bind
flavonoid
kinas
clearer
understand
structur
interact
flavonoid
kinas
necessari
allow
construct
potent
select
counterpart
wright
et
al
examin
interact
quercetin
apigenin
catechin
src
famili
kinas
lyn
fyn
hck
sever
method
includ
cmda
reveal
potenti
hydrogen
bond
contact
flavonoid
hydroxyl
kinas
catalyt
site
residu
quercetin
form
energet
stabl
interact
apigenin
lack
hydroxyl
group
necessari
import
contact
nonplanar
structur
catechin
could
support
predict
hydrogen
bond
pattern
find
wright
et
al
predict
quercetin
would
inhibit
activ
src
famili
kinas
greater
potenc
apigenin
catechin
predict
confirm
use
vitro
kinas
assay
sever
human
studi
confirm
tea
benefici
effect
infecti
diseas
exampl
casecontrol
studi
drink
green
tea
signific
neg
associ
tuberculosi
odd
ratio
catechin
antibacteri
activ
modifi
properti
multidrugresist
staphylococcu
aureu
mrsa
taylor
comprehens
discuss
bind
avid
catechin
among
ecg
show
strongest
bind
mrsa
incub
mrsa
ecg
inhibit
bacteri
growth
gave
dark
color
mrsa
indic
ecg
bound
mrsa
thu
catechin
gallat
attract
agent
therapeut
intervent
clinic
trial
sameshima
et
al
demonstr
green
tea
powder
greatli
potenti
effect
interferonrivabirin
therapi
intract
chronic
hepat
c
patient
song
review
laboratori
studi
antivir
activ
catechin
divers
famili
virus
includ
hepat
b
c
viru
human
immunodefici
viru
herp
simplex
viru
influenza
viru
cmda
provid
molecular
basi
explain
catechin
exert
antimicrobi
effect
shown
next
sharma
et
al
show
egcg
inhibit
enoylacyl
carrier
protein
reductas
mycobacterium
tuberculosi
interf
bind
nadh
enzym
direct
bind
assay
use
h
egcg
fluoresc
titrat
assay
support
inhibit
data
confirm
cmda
find
may
use
sinc
enzym
target
antitubercular
drug
univers
stress
protein
novel
target
overcom
tuberculosi
resist
cmda
experi
show
curcumin
catechin
resveratrol
hydrogen
bond
two
ionic
bond
carboxyl
group
curcumin
respect
curcumin
show
highest
bind
energi
kcal
univers
stress
protein
quercetin
catechin
larger
bind
energi
valu
ring
catechin
particip
hydrogen
bond
protein
curcumin
analogu
may
use
futur
therapi
downregul
univers
stress
protein
gradisar
et
al
examin
inhibit
catechin
bacteri
dna
gyras
b
bind
atp
bind
site
found
egcg
highest
activ
follow
ecg
egc
chemic
shift
perturb
use
determin
protein
moieti
affect
bind
egcg
cmda
suggest
benzopyran
ring
egcg
penetr
deepli
activ
site
galloyl
moieti
anchor
cleft
interact
hydroxyl
group
explain
higher
activ
egcg
ecg
egc
ec
egc
suggest
interact
gyras
mainli
interact
bring
staphylococc
enterotoxin
metabol
product
staphylococcu
aureu
respons
food
poison
result
fluoresc
emiss
spectrometri
cmda
indic
egcg
show
order
magnitud
higher
bind
constant
polyphenol
studi
egcg
similar
polyphenol
ligand
like
bind
channel
surfac
staphylococc
enterotoxin
b
respons
recognit
tcell
chain
fragment
influenc
adhes
toxin
cell
similarli
shimamura
et
al
found
egcg
bound
strongli
staphylococc
enterotoxin
sea
result
deriv
sever
method
includ
cmda
indic
hydroxyl
group
posit
galloyl
group
egcg
respons
bind
region
toxin
activ
site
figur
moreov
hydroxyl
group
ring
egcg
form
hydrophob
bond
figur
sinc
omethyl
egcg
result
weaker
bind
interact
protein
egcg
hydrogen
bond
hydroxyl
group
galloyl
group
must
import
effici
interact
lead
toxin
activ
cmda
also
predict
egc
bind
toxin
region
similar
egcg
hydroxyl
group
are
involv
bind
figur
thu
effici
inhibit
toxin
activ
account
involv
interact
galloyl
group
sea
futur
therapi
downregul
univers
stress
protein
gradisar
et
al
examin
inhibit
catechin
bacteri
dna
gyras
b
bind
atp
bind
site
found
egcg
highest
activ
follow
ecg
egc
chemic
shift
perturb
use
determin
protein
moieti
affect
bind
egcg
cmda
suggest
benzopyran
ring
egcg
penetr
deepli
activ
site
galloyl
moieti
anchor
cleft
interact
hydroxyl
group
explain
higher
activ
egcg
ecg
egc
ec
egc
suggest
interact
gyras
mainli
interact
bring
staphylococc
enterotoxin
metabol
product
staphylococcu
aureu
respons
food
poison
result
fluoresc
emiss
spectrometri
cmda
indic
egcg
show
order
magnitud
higher
bind
constant
polyphenol
studi
egcg
similar
polyphenol
ligand
like
bind
channel
surfac
staphylococc
enterotoxin
b
respons
recognit
tcell
chain
fragment
influenc
adhes
toxin
cell
similarli
shimamura
et
al
found
egcg
bound
strongli
staphylococc
enterotoxin
sea
result
deriv
sever
method
includ
cmda
indic
hydroxyl
group
posit
galloyl
group
egcg
respons
bind
region
toxin
activ
site
figur
moreov
hydroxyl
group
ring
egcg
form
hydrophob
bond
figur
sinc
egcg
result
weaker
bind
interact
protein
egcg
hydrogen
bond
hydroxyl
group
galloyl
group
must
import
effici
interact
lead
toxin
activ
cmda
also
predict
egc
bind
toxin
region
similar
egcg
hydroxyl
group
are
involv
bind
figur
thu
effici
inhibit
toxin
activ
account
involv
interact
galloyl
group
sea
studi
mechan
underli
antibacteri
activ
egcg
gramposit
bacteria
bacillu
subtili
egcg
treatment
result
format
protein
aggreg
oligopeptid
abc
transport
bind
lipoprotein
oppa
glucos
phosphotransferas
system
transport
protein
phosphat
abc
transport
substratebind
protein
penicillinbind
protein
egcg
inhibit
major
function
protein
lead
inhibit
growth
b
subtili
oppa
cmda
show
egcg
bind
basic
amino
acid
locat
inner
studi
mechan
underli
antibacteri
activ
egcg
gramposit
bacteria
bacillu
subtili
egcg
treatment
result
format
protein
aggreg
oligopeptid
abc
transport
bind
lipoprotein
oppa
glucos
phosphotransferas
system
transport
protein
phosphat
abc
transport
substratebind
protein
penicillinbind
protein
egcg
inhibit
major
function
protein
lead
inhibit
growth
b
subtili
oppa
cmda
show
egcg
bind
basic
amino
acid
locat
inner
wall
oppa
hydrogen
bond
form
stabl
complex
prevent
conform
chang
oppa
open
close
state
lead
inhibit
transport
oligopeptid
streptococcu
pneumonia
possess
numer
virul
factor
associ
pneumococc
infect
pathogenesi
pneumolysin
pli
member
cholesteroldepend
cytolysin
famili
cytolyt
activ
sortas
srta
contribut
anchor
mani
virulenceassoci
surfac
protein
cell
wall
song
et
al
show
egcg
directli
inhibit
pli
mediat
haemolysi
cytolysi
block
oligomer
pli
simultan
reduc
peptidas
activ
srta
egcg
also
inhibit
biofilm
format
product
neuraminidas
bacteri
adhes
human
epitheli
cell
cmda
mutat
analysi
predict
egcg
bind
pli
srta
figur
sinc
egcg
protect
mice
pneumonia
pneumonia
egcg
may
promis
therapeut
option
diseas
bind
human
immunodefici
viru
type
cell
surfac
initi
step
viral
entri
cell
egcg
inhibitor
block
bind
hamza
et
al
examin
inhibitori
mechan
use
cmda
method
predict
favor
structur
bind
complex
water
egcg
bound
way
calcul
bind
affin
complex
neglig
favor
bind
egcg
effect
block
bind
suggest
egcg
block
bind
find
would
use
develop
nextgener
drug
wall
oppa
hydrogen
bond
form
stabl
complex
prevent
conform
chang
oppa
open
close
state
lead
inhibit
transport
oligopeptid
streptococcu
pneumonia
possess
numer
virul
factor
associ
pneumococc
infect
pathogenesi
pneumolysin
pli
member
cholesteroldepend
cytolysin
famili
cytolyt
activ
sortas
srta
contribut
anchor
mani
virulenceassoci
surfac
protein
cell
wall
song
et
al
show
egcg
directli
inhibit
pli
mediat
haemolysi
cytolysi
block
oligomer
pli
simultan
reduc
peptidas
activ
srta
egcg
also
inhibit
biofilm
format
product
neuraminidas
bacteri
adhes
human
epitheli
cell
cmda
mutat
analysi
predict
egcg
bind
pli
srta
figur
sinc
egcg
protect
mice
pneumonia
pneumonia
egcg
may
promis
therapeut
option
diseas
bind
human
immunodefici
viru
type
cell
surfac
initi
step
viral
entri
cell
egcg
inhibitor
block
bind
hamza
et
al
examin
inhibitori
mechan
use
cmda
method
predict
favor
structur
bind
complex
water
egcg
bound
way
calcul
bind
affin
complex
neglig
favor
bind
egcg
effect
block
bind
suggest
egcg
block
bind
find
would
use
develop
nextgener
drug
proteas
sever
acut
respiratori
syndromeassoci
coronavirus
play
pivot
role
viral
replic
promis
drug
target
nguyen
et
al
use
recombin
studi
inhibit
kinet
seven
plant
flavonoid
valu
flavonoid
rang
quercetin
egcg
gallocatechin
gallat
gcg
good
inhibitor
respect
gcg
exhibit
competit
inhibit
pki
valu
cmda
show
gcg
bind
energi
around
kcalmol
activ
site
galloyl
moieti
posit
requir
inhibit
activ
derksen
et
al
examin
antiinfluenza
viru
iav
potenti
proanthocyanidinenrich
extract
aerial
part
rumex
acetosa
ra
extract
inhibit
growth
iav
strain
clinic
isol
iav
respect
ra
extract
also
activ
oseltamivirresist
isol
procyanidin
pbd
identifi
main
activ
principl
ra
ca
ra
pbd
block
attach
iav
proteas
sever
acut
respiratori
syndromeassoci
coronavirus
play
pivot
role
viral
replic
promis
drug
target
nguyen
et
al
use
recombin
studi
inhibit
kinet
seven
plant
flavonoid
valu
flavonoid
rang
quercetin
egcg
gallocatechin
gallat
gcg
good
inhibitor
respect
gcg
exhibit
competit
inhibit
pki
valu
cmda
show
gcg
bind
energi
around
kcalmol
activ
site
galloyl
moieti
posit
requir
inhibit
activ
derksen
et
al
examin
antiinfluenza
viru
iav
potenti
proanthocyanidinenrich
extract
aerial
part
rumex
acetosa
ra
extract
inhibit
growth
iav
strain
clinic
isol
iav
respect
ra
extract
also
activ
oseltamivirresist
isol
procyanidin
ogal
pbd
identifi
main
activ
principl
ra
ca
ra
pbd
block
attach
iav
interf
viral
penetr
higher
concentr
galloyl
procyanidin
core
structur
prerequisit
antiiav
activ
otrihydroxyl
bring
increas
antiiav
activ
cmda
indic
pbd
interact
receptor
bind
site
iav
hemagglutinin
ra
pbd
appear
promis
expans
current
avail
antiinfluenza
agent
chikungunya
fever
viral
diseas
may
caus
chronic
arthriti
jain
et
al
evalu
proteinligand
interact
chikungunya
viru
protein
natur
compound
identifi
potenti
inhibitor
method
includ
cmda
found
rosmarin
acid
interact
viral
capsid
protein
top
dock
conform
show
predict
bind
energi
kcalmol
rosmarin
acid
slightli
larger
bind
energi
compound
may
serv
lead
compound
develop
antivir
drug
fatima
et
al
prepar
hcv
helicas
pakistani
hcv
serum
sampl
conduct
cmda
base
structur
identifi
inhibitor
hcv
genotyp
among
variou
compound
includ
quercetin
catechin
resveratrol
lutein
former
two
compound
show
good
hydrogen
bond
interact
best
dock
energi
antihelicas
molecul
would
offer
clue
develop
antivir
drug
addit
cmda
studi
interact
catechin
cholera
toxin
dengu
viru
envelop
glycoprotein
e
papillomaviru
oncoprotein
alreadi
discuss
egcg
catechin
deriv
suggest
role
prevent
agent
immunolog
disord
food
allergi
rheumatoid
arthriti
sever
human
cellular
anim
experi
shown
catechin
benefici
effect
allergi
rheumatoid
arthriti
exampl
random
doubleblind
placebocontrol
trial
show
green
tea
contain
omethyl
catechin
reduc
symptom
japanes
cedar
pollinosi
anim
model
arthriti
therapeut
effect
egcg
report
compar
methotrex
wellknown
antirheumatoid
arthriti
drug
cmda
provid
inform
interact
catechin
protein
relat
immunolog
diseas
two
studi
discuss
earlier
cmda
analysi
show
egcg
bind
pocket
partli
overlap
igebind
region
ovalbumin
major
dietari
allergen
interact
induc
structur
chang
ovalbumin
ex
vivo
studi
reveal
ovalbumin
bound
ige
stimul
degranul
basophil
egcg
slow
uptak
monocyt
thu
egcg
might
interact
food
allergen
impair
antigen
uptak
antigenpres
cell
peanut
albumin
seed
storag
protein
major
elicitor
anaphylact
reaction
peanut
use
variou
method
includ
cmda
elucid
interact
egcg
vesic
et
al
demonstr
similar
structur
overal
fold
albumin
yield
similar
put
bind
site
similar
bind
mode
egcg
bind
egcg
albumin
affect
protein
conform
caus
transit
effect
egcg
anaphylact
reaction
remain
unknown
xing
et
al
examin
antiinflammatori
effect
procyanidin
catechin
oligom
deriv
biochem
method
cmda
identifi
tolllik
receptor
myeloid
differenti
factor
critic
site
hydrogen
bond
procyanidin
similar
site
occupi
lp
product
significantli
decreas
procyanidin
lpstreat
cell
procyanidin
also
significantli
decreas
phosphoryl
mapk
protein
well
mrna
level
procyanidin
compet
lp
bind
complex
suppress
downstream
activ
mapk
signal
pathway
result
collect
indic
catechin
effect
inhibit
downstream
inflammatori
signal
noncoval
interact
addit
hydrogen
bond
egcg
catechin
deriv
protein
like
contribut
divers
biolog
activ
mani
research
group
report
tannin
function
antioxid
anticarcinogen
use
combin
comput
biochem
assay
shraberg
et
al
demonstr
procyanidin
tannin
stereoisom
procyanidin
exhibit
differ
bind
affin
salivari
peptid
histatin
electron
spray
ioniz
mass
spectroscopi
comput
analysi
cmda
molecular
dynam
simul
suggest
tannin
make
close
contact
varieti
amino
acid
residu
peptid
involv
peroxidas
polyphenol
oxidas
ppo
enzymat
brown
reaction
fruit
veget
differ
catalyt
mechan
well
establish
enzym
common
substrat
also
specif
substrat
nokthai
et
al
conduct
comput
studi
construct
model
employ
amino
acid
sequenc
grape
peroxidas
homolog
model
method
base
xray
structur
ascorb
peroxidas
pea
protein
data
base
pdb
model
grape
ppo
obtain
directli
xray
structur
pdb
report
previous
cmda
common
substrat
enzym
reveal
ec
catechin
exhibit
high
affin
enzym
although
peroxidas
ppo
bind
pocket
differ
size
key
particip
amino
acid
calcul
dock
interact
energi
trihydroxybenzo
acidrel
compound
led
suggest
compound
potenti
common
inhibitor
ascorb
peroxidas
ppo
compar
cmda
catechinprotein
complex
studi
less
extens
xca
exampl
pubm
report
four
origin
studi
date
search
keyword
egcg
protein
interact
xray
gener
xca
provid
detail
inform
molecular
interact
protein
ligand
cmda
previou
paper
review
xca
egcgpin
egcglutam
dehydrogenas
gdh
egcgtransthyretin
complex
extend
discuss
use
homoco
model
proteincompound
complex
structur
server
analyz
interact
catechin
protein
ligandprotein
interact
defin
rcsb
pdb
ligand
explor
ver
tabl
summar
find
catechinprotein
complex
word
parenthes
indic
main
chain
side
chain
atom
particip
hydrogen
bond
egc
lack
galloyl
moieti
bind
substrat
bind
site
iron
cofactor
resolut
definit
criterion
solut
nmr
water
atom
observ
low
resolut
vigor
motion
solut
nmr
method
ara
h
peanut
allergen
thought
respons
oral
allergi
syndrom
ara
h
bind
ec
complex
determin
resolut
xca
show
graphic
depict
interact
ec
protein
figur
leucoanthocyanidin
reductas
enzym
catalyz
nadphdepend
reduct
flavandiol
subfamili
flavonoid
may
possess
benefici
properti
human
health
maug
et
al
conduct
xca
leucoanthocyanidin
reductas
viti
vinifera
complex
nadph
catechin
result
shown
figur
structur
ternari
complex
determin
resolut
indic
interact
catechin
nicotinamid
ring
nadph
suggest
act
acidbas
catalyst
result
indic
catechin
could
bind
activ
site
interact
directli
cofactor
strawberri
allergen
fra
protein
involv
mani
aspect
plant
biolog
relat
sequenc
structur
homolog
mammalian
lipid
transport
receptor
protein
et
al
show
protein
bind
natur
flavonoid
differ
select
affin
xca
fra
fra
complex
catechin
indic
sever
loop
structur
ternari
complex
determin
resolut
indic
interact
catechin
nicotinamid
ring
nadph
suggest
act
acidbas
catalyst
result
indic
catechin
could
bind
activ
site
interact
directli
cofactor
strawberri
allergen
fra
protein
involv
mani
aspect
plant
biolog
relat
sequenc
structur
homolog
mammalian
lipid
transport
receptor
protein
et
al
show
protein
bind
natur
flavonoid
differ
select
affin
xca
fra
fra
complex
catechin
indic
sever
loop
surround
ligandbind
caviti
signific
flexibl
apo
form
would
close
upon
ligand
catechin
bind
are
near
iron
cofactor
attach
hydrogen
bond
cterminu
enzym
bring
hydroxyl
group
particip
hydrogen
bond
van
der
waal
interact
form
surround
amino
acid
water
molecul
like
hydrogen
bond
interact
catechin
fra
observ
vigor
motion
addit
xca
show
sever
hydrogen
bond
catechin
protein
also
catechin
water
reveal
cmda
averag
number
hydrogen
bond
atom
make
hydrophob
contact
ecwat
ecprotein
respect
except
lowresolut
fra
complex
tabl
gdh
catalyz
oxid
deamin
lglutam
mutat
caus
hyperinsulin
hyperammonemia
syndrom
anim
gtc
especi
egc
control
dysregul
gdh
hijack
adp
activ
site
xca
gdhegc
complex
also
discuss
previou
paper
lipoxygenas
nonhem
ironcontain
enzym
ubiquit
present
natur
catalyz
oxygen
polyunsatur
fatti
acid
catechin
natur
flavonoid
known
inhibitori
activ
toward
dioxygenas
potenti
util
prevent
treatment
inflammatori
diseas
cancer
xca
soybean
complex
egcg
reveal
inhibitor
depict
egc
lack
galloyl
moieti
figur
extens
hydrophob
contact
lipoxygenas
egc
egcg
may
contribut
strong
inhibitori
effect
enzymat
activ
kowalinski
et
al
conduct
xca
pandem
pa
endonucleas
domain
inhibitor
includ
egcg
four
diketo
compound
chelat
two
critic
manganes
ion
activ
site
enzym
data
show
differ
substitu
group
basic
metal
bind
scaffold
orient
bind
distinct
subpocket
within
activ
site
caviti
plastic
certain
structur
element
activ
site
caviti
result
induc
fit
bind
figur
find
may
import
optim
design
potent
inhibitor
target
viru
polymeras
heart
muscl
contract
regul
ca
bind
thin
filament
protein
troponin
c
cardiovascular
diseas
respons
myofila
ca
often
alter
compound
restor
perturb
may
use
therapeut
method
includ
cmda
reveal
egcg
bind
site
ctermin
domain
troponin
c
lie
hydrophob
pocket
absenc
troponin
bind
presenc
troponin
may
new
site
form
troponin
ctroponin
complex
interact
egcg
ctermin
domain
troponin
ctroponin
complex
shown
cardioton
molecul
may
provid
potenti
mechan
egcg
modul
heart
contract
previous
egcg
shown
bind
directli
peptidyl
prolyl
cistran
isomeras
play
critic
role
oncogen
signal
egcg
also
report
bind
transthyretin
involv
pathogenesi
famili
amyloid
polyneuropathi
diseas
caus
point
mutat
transthyretin
thyroxin
transport
egcg
shown
suppress
amyloid
fibril
format
xca
certain
featur
egcg
complex
transthyretin
also
describ
previous
three
common
featur
catechinprotein
interact
frequent
occurr
hydrogen
bond
hydroxyl
group
are
bring
galloyl
group
catechin
side
chain
asp
glu
arg
ii
trp
phe
form
interact
tyr
may
rare
involv
interact
iii
highest
frequenc
found
hydrophob
interact
leu
follow
phe
ile
among
protein
examin
highest
incid
hydrogen
bond
found
egcgpa
endonucleas
complex
tabl
shown
figur
egcg
predict
bind
protein
surfac
four
egcgprotein
complex
hydrophil
natur
galloyl
group
might
involv
interact
water
molecul
addit
hydrophob
interact
frequent
found
egcg
interact
branch
chain
amino
acid
leuvalil
phe
cmda
xca
provid
detail
inform
interact
catechin
protein
gener
gallatecontain
catechin
higher
biolog
activ
catechin
without
galloyl
group
structureact
mostli
explain
cmda
xca
show
import
role
galloyl
group
catechinprotein
molecular
interact
typic
illustr
interact
trypsin
galloyl
group
egcg
interact
activ
caviti
bring
catechin
figur
anoth
exampl
may
studi
staphylococc
enterotoxin
egcg
egc
bind
bioactiv
domain
respons
group
differ
hydroxyl
group
galloyl
group
egcg
are
egc
figur
provid
reason
egcg
display
inhibitori
activ
activ
toxin
increas
number
galloyl
group
may
one
strategi
drug
develop
base
cmda
farhan
et
al
propos
synthesi
novel
anticanc
drug
mani
galloyl
moieti
possibl
would
provid
increas
number
hydroxyl
group
facilit
bind
target
macromolecul
addit
cmda
xca
studi
propos
conform
chang
protein
induc
bind
egcg
serum
immunoglobulin
cmda
xca
provid
detail
inform
interact
catechin
protein
gener
gallatecontain
catechin
higher
biolog
activ
catechin
without
galloyl
group
structureact
mostli
explain
cmda
xca
show
import
role
galloyl
group
catechinprotein
molecular
interact
typic
illustr
interact
trypsin
galloyl
group
egcg
interact
activ
caviti
bring
catechin
figur
anoth
exampl
may
studi
staphylococc
enterotoxin
egcg
egc
bind
bioactiv
domain
respons
group
differ
hydroxyl
group
galloyl
group
egcg
are
egc
figur
provid
reason
egcg
display
inhibitori
activ
activ
toxin
increas
number
galloyl
group
may
one
strategi
drug
develop
base
cmda
farhan
et
al
propos
synthesi
novel
anticanc
drug
mani
galloyl
moieti
possibl
would
provid
increas
number
hydroxyl
group
facilit
bind
target
macromolecul
addit
cmda
xca
studi
propos
conform
chang
protein
induc
bind
egcg
serum
immunoglobulin
light
chain
shown
figur
note
basic
studi
use
cmda
xca
often
conduct
catechin
without
gallat
residu
describ
futur
studi
includ
galloyl
catechin
moreov
cmda
xca
studi
examin
protein
interact
one
type
catechin
exampl
egcg
absenc
catechin
relat
compound
synergist
effect
egcg
chemic
includ
catechin
often
observ
therefor
would
also
import
examin
synergi
competit
among
catechin
protein
interact
cmda
xca
assess
exampl
protein
interact
egcg
presenc
egc
taken
togeth
cmda
xca
effect
method
examin
ligandprotein
interact
screen
lead
chemic
compound
chemic
modif
guid
structur
ligandbas
comput
methodolog
would
lead
discoveri
better
clinic
drug
candid
fund
research
support
part
grantsinaid
scientif
research
japan
societi
promot
scienc
sohei
ito
shogo
nakano
fund
part
consign
project
economi
industri
depart
shizuoka
prefectur
govern
yoriyuki
nakamura
author
declar
conflict
interest
